DISCHARGE OF MORTGAGEIgi Inc • March 10th, 2003 • Biological products, (no disgnostic substances)
Company FiledMarch 10th, 2003 Industry
EMPLOYMENT AGREEMENT DATE: December 17, 2004 PARTIES: Techne Corporation, a Minnesota corporation 614 McKinley Place N.E. Minneapolis, Minnesota 55413 Gregory J. Melsen AGREEMENTS: ARTICLE 1. TERM OF EMPLOYMENT: DUTIES AND SUPERVISION 1.1) Parties....Employment Agreement • December 20th, 2004 • Techne Corp /Mn/ • Biological products, (no disgnostic substances) • Minnesota
Contract Type FiledDecember 20th, 2004 Company Industry Jurisdiction
RECITALSRegistration Rights Agreement • April 4th, 2006 • Brainstorm Cell Therapeutics Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledApril 4th, 2006 Company Industry Jurisdiction
EXHIBIT 99.2 Published CUSIP Number: [________________] CREDIT AGREEMENT Dated as of June 29, 2007Credit Agreement • July 2nd, 2007 • Biogen Idec Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 2nd, 2007 Company Industry Jurisdiction
Exhibit 10.3 SIXTH AMENDMENT TO EMPLOYMENT AGREEMENT This AMENDMENT TO EMPLOYMENT AGREEMENT (the " Sixth Amendment") made as of September 2, 2003 between ARIAD Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and David Berstein, Esq....Employment Agreement • November 4th, 2003 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledNovember 4th, 2003 Company Industry Jurisdiction
MADE AS OF JUNE 1, 1998, BETWEENStock Purchase Agreement • February 5th, 1999 • Phoenix International Industries Inc /Fl/ • Biological products, (no disgnostic substances) • Georgia
Contract Type FiledFebruary 5th, 1999 Company Industry Jurisdiction
as Issuer andIndenture • May 25th, 2006 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 25th, 2006 Company Industry Jurisdiction
WITNESSETH:Lease Agreement • August 9th, 2007 • Third Wave Technologies Inc /Wi • Biological products, (no disgnostic substances) • Wisconsin
Contract Type FiledAugust 9th, 2007 Company Industry Jurisdiction
Exhibit 10.12 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the "Agreement") is entered into as of the first day of November, 2004, by and between Daniel J. Kerkman ("Employee"), and APPLIED NEUROSOLUTIONS, INC. ("APNS"), a Delaware corporation...Employment Agreement • March 25th, 2005 • Applied Neurosolutions Inc • Biological products, (no disgnostic substances) • Illinois
Contract Type FiledMarch 25th, 2005 Company Industry Jurisdiction
Exhibit 10.4 THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD,...Brainstorm Cell Therapeutics Inc • April 4th, 2006 • Biological products, (no disgnostic substances) • Washington
Company FiledApril 4th, 2006 Industry Jurisdiction
EXHIBIT 10.55 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (the "Agreement") is made as of October 5, 2001 (the "Effective Date") by and between ARIAD Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and Brian A. Lajoie (the...Consulting Agreement • March 22nd, 2002 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledMarch 22nd, 2002 Company Industry Jurisdiction
RECITALSAgreement • January 30th, 2003 • Vitro Diagnostics Inc • Biological products, (no disgnostic substances)
Contract Type FiledJanuary 30th, 2003 Company Industry
EXHIBIT 4.2Escrow Agreement • March 4th, 2005 • Xechem International Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 4th, 2005 Company Industry Jurisdiction
RECITALSPurchase Agreement • February 13th, 2004 • Hemoxymed Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 13th, 2004 Company Industry Jurisdiction
EXHIBIT 4.2 THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD,...Stem Cell Innovations, Inc. • November 22nd, 2006 • Biological products, (no disgnostic substances) • New York
Company FiledNovember 22nd, 2006 Industry Jurisdiction
PRE-FUNDED COMMON STOCK WARRANT Surrozen, Inc.Surrozen, Inc./De • April 2nd, 2024 • Biological products, (no disgnostic substances)
Company FiledApril 2nd, 2024 IndustryTHIS PREFUNDED COMMON STOCK WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Surrozen, Inc., a Delaware corporation (the “Company”), up to ______ shares of Common Stock(as subject to adjustment hereunder, the “Warrant Shares”) . The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
RECITALSVoting Agreement • February 28th, 2003 • Enzon Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledFebruary 28th, 2003 Company Industry Jurisdiction
Pledgor has, on this date, executed and delivered to Pledgees or their assigns a promissory note dated the date hereof in the principal amount of Two Hundred Seventy Nine Million Four Hundred Seventeen Thousand and Nine Hundred Eighty- two Dollars...Pledge Agreement • January 18th, 2002 • Immunex Corp /De/ • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 18th, 2002 Company Industry Jurisdiction
ANDManagement Agreement • September 8th, 2003 • Zein Youssef El • Biological products, (no disgnostic substances) • Isle of Man
Contract Type FiledSeptember 8th, 2003 Company Industry Jurisdiction
Exhibit 10.20 BIOSANTE PHARMACEUTICALS, INC. SUBSCRIPTION AGREEMENT BioSante Pharmaceuticals, Inc. 175 Olde Half Day Road, Suite 247 Lincolnshire, IL 60069 Attn: Mr. Stephen M. Simes Ladies and Gentlemen: 1. SUBSCRIPTION. The undersigned is hereby...Subscription Agreement • June 29th, 2001 • Biosante Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Illinois
Contract Type FiledJune 29th, 2001 Company Industry Jurisdiction
EXHIBIT 10.1 CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASSIGNMENT AND...Stock Purchase Agreement • July 27th, 2005 • Neurocrine Biosciences Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 27th, 2005 Company Industry Jurisdiction
EXECUTION COPYLoan and Security Agreement • March 22nd, 2002 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledMarch 22nd, 2002 Company Industry Jurisdiction
EXHIBIT 10.13 EMPLOYMENT AGREEMENT THIS AGREEMENT, made effective as of this 1st day of January, 2003, by and between STEVEN A. GOULD, M.D. ("Employee") and NORTHFIELD LABORATORIES INC., a Delaware corporation (the "Company"). W I T N E S S E T H : -...Employment Agreement • June 27th, 2003 • Northfield Laboratories Inc /De/ • Biological products, (no disgnostic substances) • Illinois
Contract Type FiledJune 27th, 2003 Company Industry Jurisdiction
EXHIBIT 10.2 DISTRIBUTION AGREEMENTDistribution Agreement • May 14th, 2003 • Senetek PLC /Eng/ • Biological products, (no disgnostic substances)
Contract Type FiledMay 14th, 2003 Company Industry
Exhibit 10.13 BRAINSTORM CELL THERAPEUTICS INC. OPTION AGREEMENT Made effective as of the 31st day of December, 2004 BETWEEN: Brainstorm Cell Therapeutics Inc. A company incorporated in Washington (hereinafter the "Company")Option Agreement • April 1st, 2005 • Brainstorm Cell Therapeutics Inc • Biological products, (no disgnostic substances)
Contract Type FiledApril 1st, 2005 Company Industry
BY AND AMONG AMGEN INC.,Agreement and Plan of Merger • December 17th, 2001 • Amgen Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledDecember 17th, 2001 Company Industry Jurisdiction
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 19th, 2023 • Brainstorm Cell Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 19th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of _______ between Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
BY AND AMONGAgreement and Plan of Merger • May 2nd, 2005 • Corixa Corp • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMay 2nd, 2005 Company Industry Jurisdiction
FIRST SUPPLEMENTAL INDENTURESupplemental Indenture • January 15th, 1998 • Hybridon Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 15th, 1998 Company Industry Jurisdiction
RECITALS:Stock Option Agreement • March 9th, 2005 • Xechem International Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMarch 9th, 2005 Company Industry Jurisdiction
EXHIBIT 10(sss) SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this "Agreement") is dated as of April 30, 2017, between CEL-SCI Corporation, a Colorado corporation (the "Company"), and each purchaser identified on the signature...Securities Purchase Agreement • May 2nd, 2017 • Cel Sci Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 2nd, 2017 Company Industry Jurisdiction
EXHIBIT 99.1 LOAN AGREEMENT Dated as of June 28, 2007Loan Agreement • July 2nd, 2007 • Biogen Idec Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 2nd, 2007 Company Industry Jurisdiction
Exhibit 99.1 AGREEMENTAgreement • August 11th, 2006 • Qubit Holdings LLC • Biological products, (no disgnostic substances)
Contract Type FiledAugust 11th, 2006 Company IndustryThe undersigned agree that this Schedule 13D, dated as of the date hereof, relating to the Common Stock, par value $0.0025 per share, of The Immune Response Corporation, shall be filed on behalf of the undersigned.
ARTICLE I. DEFINITIONSRevolving Credit Agreement • February 13th, 2003 • Lifecore Biomedical Inc • Biological products, (no disgnostic substances) • Minnesota
Contract Type FiledFebruary 13th, 2003 Company Industry Jurisdiction
EXHIBIT 99.4 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this "Agreement") is made and entered into as of June 11, 2008, by and among MicroIslet, Inc., a Nevada corporation (the "Company"), and the investors from time to time...Registration Rights Agreement • June 17th, 2008 • Microislet Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledJune 17th, 2008 Company Industry Jurisdiction